Wilmington Savings Fund Society FSB Has $16.89 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Wilmington Savings Fund Society FSB raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 209.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,886 shares of the healthcare conglomerate’s stock after purchasing an additional 19,566 shares during the period. Wilmington Savings Fund Society FSB’s holdings in UnitedHealth Group were worth $16,889,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in UNH. Arvest Bank Trust Division acquired a new position in UnitedHealth Group in the 3rd quarter valued at $1,154,000. Sfmg LLC increased its position in shares of UnitedHealth Group by 3.8% in the third quarter. Sfmg LLC now owns 1,537 shares of the healthcare conglomerate’s stock worth $898,000 after purchasing an additional 56 shares during the period. World Investment Advisors LLC lifted its position in UnitedHealth Group by 239.4% during the third quarter. World Investment Advisors LLC now owns 41,575 shares of the healthcare conglomerate’s stock worth $24,308,000 after purchasing an additional 29,324 shares during the period. Sanctuary Advisors LLC raised its position in shares of UnitedHealth Group by 17.0% in the 3rd quarter. Sanctuary Advisors LLC now owns 145,278 shares of the healthcare conglomerate’s stock valued at $85,841,000 after buying an additional 21,084 shares in the last quarter. Finally, Pine Valley Investments Ltd Liability Co increased its stake in UnitedHealth Group by 5.2% in the third quarter. Pine Valley Investments Ltd Liability Co now owns 18,963 shares of the healthcare conglomerate’s stock valued at $11,087,000 after acquiring an additional 930 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH opened at $529.07 on Thursday. The stock has a market capitalization of $486.89 billion, a P/E ratio of 34.75, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s fifty day simple moving average is $584.83 and its two-hundred day simple moving average is $559.60. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business earned $6.56 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.59%. UnitedHealth Group’s payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Cantor Fitzgerald lifted their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday. Truist Financial reaffirmed a “buy” rating and set a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $626.84.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.